How Much Upside is Left in Kiniksa Pharmaceuticals (KNSA)? Wall Street Analysts Think 58.6%
Portfolio Pulse from
Wall Street analysts have set an average price target for Kiniksa Pharmaceuticals (KNSA) that suggests a potential upside of 58.6%. This is supported by positive trends in earnings estimate revisions.
March 19, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wall Street analysts suggest a 58.6% upside for Kiniksa Pharmaceuticals (KNSA) based on average price targets. Positive earnings estimate revisions support this potential increase.
The article highlights a significant potential upside for KNSA based on analyst price targets and positive earnings estimate revisions. This suggests a likely positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100